Publications by authors named "Mar Martinez Quesada"
Article Synopsis
- Lipoprotein(a) [Lp(a)] is a particle linked to higher cardiovascular risk and is largely influenced by genetics, prompting this study to investigate Lp(a) levels in relatives of patients with acute coronary syndrome (ACS).
- A multicenter study included 413 subjects, where 56.4% were first-degree relatives of patients with Lp(a) levels ≥ 50 mg/dL; notably, 57.5% had a family history of early ischemic heart disease, and only 20.6% were on statin treatment.
- Findings showed that 59.4% of these relatives had elevated Lp(a) levels, which were comparable to the patients, indicating a familial predisposition to high L
Introduction: SmartLab 2.0 is an innovative concept of multidisciplinary collaboration between the clinical laboratory and the diabetes day unit that was born with the aim of identifying patients at high cardiovascular risk who require priority attention, such as patients with atherogenic dyslipidemia, in order to create a cardiovascular prevention strategy.
Objective: Implementation in the Laboratory Information System (LIS) of an automated biochemical algorithm for the identification of patients with atherogenic dyslipidemia in routine analyses and priority referral to the diabetes day unit.
Background And Aim Of The Study: The development of mitral regurgitation (MR) soon after acute myocardial infarction (AMI) is a recognized and frequent complication. Its negative impact on survival has been observed after Q-wave AMI, even when of a mild degree, and independently of left ventricular systolic function. Few data exist regarding MR after non-Q-wave AMI (nQ AMI), however.
View Article and Find Full Text PDFReal-time 3-dimensional echocardiography allows a comprehensive evaluation of left ventricular outflow tract (LVOT) obstruction in patients with hypertrophic cardiomyopathy. The anterior segment of the anterior mitral leaflet is essential in the development of the LVOT pressure gradient.
View Article and Find Full Text PDFPrimary cardiac tumors are infrequent and usually benign. They can manifest as dyspnea, chest pain, palpitations, sudden death, peripheral embolism, cyanosis, or general symptoms. They are sometimes an incidental finding in an asymptomatic patient.
View Article and Find Full Text PDF